Jonathan Quick
Corporate Officer/Principal at LOGICBIO THERAPEUTICS, INC.
Profile
Presently, Jonathan Quick occupies the position of Vice President-Finance at LogicBio Therapeutics, Inc.
In the past Mr. Quick was Director-Financial Reporting, Planning & Analysis at Celldex Therapeutics, Inc. and Director-SEC Reporting & Technical Accounting at Karyopharm Therapeutics, Inc.
Jonathan Quick received an undergraduate degree from Providence College.
Jonathan Quick active positions
Companies | Position | Start |
---|---|---|
LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Former positions of Jonathan Quick
Companies | Position | End |
---|---|---|
KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Jonathan Quick
Providence College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CELLDEX THERAPEUTICS, INC. | Health Services |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |